Stock Earnings

Question 1

Quels sont les états financiers clés de Aeolus Pharmaceuticals Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Aeolus Pharmaceuticals Inc a un total d'actifs de $4, un bénéfice net loss de $-6

Question 2

Quels sont les ratios financiers clés pour AOLS ?

Accepted Answer

Le ratio de liquidité de Aeolus Pharmaceuticals Inc est 0, la marge nette est -300, les ventes par action sont de $0.01.

Question 3

Comment les revenus de Aeolus Pharmaceuticals Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Aeolus Pharmaceuticals Inc data is not available.

Question 4

Aeolus Pharmaceuticals Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Aeolus Pharmaceuticals Inc a un bénéfice net loss de $-6

Question 5

Aeolus Pharmaceuticals Inc a-t-elle des passifs ?

Accepted Answer

no, Aeolus Pharmaceuticals Inc a un passif de 0

Question 6

Combien d'actions en circulation Aeolus Pharmaceuticals Inc a-t-elle ?

Accepted Answer

Aeolus Pharmaceuticals Inc a un total d'actions en circulation de 152.08

Breakdown	TTM	09/30/2016	09/30/2015	09/30/2014	09/30/2013	09/30/2012
Revenue	0	2	3	9	3	7
Revenue Growth (YoY)	-100%	-33%	-67%	200%	-56.99%	75%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	2	2	2	2	3	3
Research & Development	2	2	3	6	3	6
Operating Expenses	4	5	5	9	6	9
Other Non Operating Income (Expenses)	--	--	--	0	--	4
Pretax Income	-4	-3	-2	0	-3	1
Income Tax Expense	--	--	--	--	0	0
Net Income	-4	-6	-2	0	-3	0
Net Income Growth	-20%	200%	--	-100%	--	--
Shares Outstanding (Diluted)	152.08	148.66	135.88	134.66	106.55	71.04
Shares Change (YoY)	0%	9%	1%	26%	50%	-17%
EPS (Diluted)	-0.02	-0.04	-0.01	0	-0.03	0.01
EPS Growth	-25%	111%	3,117%	-98%	-401%	--
Free Cash Flow	-3	-3	-2	0	-2	0
Free Cash Flow Per Share	-0.01	-0.02	-0.01	0	-0.01	0
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-150%	-66.66%	0%	-66.66%	-28.57%
Profit Margin	0%	-300%	-66.66%	0%	-100%	0%
Free Cash Flow Margin	0%	-150%	-66.66%	0%	-66.66%	0%
EBITDA	--	--	--	0	-2	-2
EBITDA Margin	--	--	--	0%	-66.66%	-28.57%
D&A For EBITDA	--	--	--	0	0	0
EBIT	-4	-3	-2	0	-2	-2
EBIT Margin	0%	-150%	-66.66%	0%	-66.66%	-28.57%
Effective Tax Rate	--	--	--	--	0%	0%

Aeolus Pharmaceuticals Inc (AOLS) Price